Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.29 HKD | +0.19% | -1.31% | -4.68% |
Apr. 24 | Sinohealth Holdings Profit Nearly Doubles in 2023 | MT |
Mar. 28 | Sinohealth Holdings Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 25 September 2024 | CI |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|
Capitalization 1 | 2,194 | 2,175 | 2,034 | - | - |
Enterprise Value (EV) 1 | 2,194 | 2,175 | 2,034 | 2,034 | 2,034 |
P/E ratio | 35.8 x | 21.1 x | 23.3 x | 18.9 x | 16.3 x |
Yield | - | - | - | - | - |
Capitalization / Revenue | 6.15 x | 5.49 x | 4.41 x | 3.87 x | 3.46 x |
EV / Revenue | 6.15 x | 5.49 x | 4.41 x | 3.87 x | 3.46 x |
EV / EBITDA | 74 x | 20.9 x | 19.7 x | 15.5 x | 13.2 x |
EV / FCF | - | - | 24.8 x | 23.4 x | 19.9 x |
FCF Yield | - | - | 4.03% | 4.28% | 5.01% |
Price to Book | - | - | - | - | - |
Nbr of stocks (in thousands) | 451,770 | 431,185 | 414,956 | - | - |
Reference price 2 | 4.857 | 5.044 | 4.902 | 4.902 | 4.902 |
Announcement Date | 3/29/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net sales 1 | - | 356.7 | 396.2 | 461 | 525 | 588 |
EBITDA 1 | - | 29.65 | 103.9 | 103 | 131 | 154 |
EBIT 1 | - | 20.92 | 95.33 | 99 | 124 | 149 |
Operating Margin | - | 5.87% | 24.06% | 21.48% | 23.62% | 25.34% |
Earnings before Tax (EBT) 1 | - | - | 110.7 | 119 | 145 | 171 |
Net income 1 | 78.81 | 55.76 | 102 | 89 | 109 | 128 |
Net margin | - | 15.63% | 25.75% | 19.31% | 20.76% | 21.77% |
EPS 2 | 25.23 | 0.1358 | 0.2394 | 0.2100 | 0.2600 | 0.3000 |
Free Cash Flow 1 | - | - | - | 82 | 87 | 102 |
FCF margin | - | - | - | 17.79% | 16.57% | 17.35% |
FCF Conversion (EBITDA) | - | - | - | 79.61% | 66.41% | 66.23% |
FCF Conversion (Net income) | - | - | - | 92.13% | 79.82% | 79.69% |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 6/27/22 | 3/29/23 | 3/28/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 | 2023 S2 |
---|---|---|
Net sales 1 | 145 | 251.2 |
EBITDA 1 | 22.28 | 81.61 |
EBIT 1 | 17.72 | 77.61 |
Operating Margin | 12.23% | 30.89% |
Earnings before Tax (EBT) 1 | 47.89 | 62.85 |
Net income | 47.83 | - |
Net margin | 33% | - |
EPS 2 | 0.1100 | 0.1294 |
Dividend per Share | - | - |
Announcement Date | 8/25/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | 82 | 87 | 102 |
ROE (net income / shareholders' equity) | - | 10% | - | 11.9% | 12.9% | 13.3% |
ROA (Net income/ Total Assets) | - | 9.27% | - | 10.5% | 11.5% | 12% |
Assets 1 | - | 601.3 | - | 847.6 | 947.8 | 1,067 |
Book Value Per Share | - | - | - | - | - | - |
Cash Flow per Share 2 | - | - | - | 0.2100 | 0.2100 | 0.2500 |
Capex 1 | - | 2.86 | - | 7 | 4 | 6 |
Capex / Sales | - | 0.8% | - | 1.52% | 0.76% | 1.02% |
Announcement Date | 6/27/22 | 3/29/23 | 3/28/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.68% | 280M | |
+13.20% | 68.44B | |
+6.80% | 17.28B | |
+21.29% | 13.67B | |
+8.24% | 13.08B | |
+14.88% | 9.87B | |
-20.48% | 6.92B | |
-4.70% | 5.82B | |
+3.43% | 5.22B | |
+6.41% | 4.79B |
- Stock Market
- Equities
- 2361 Stock
- Financials Sinohealth Holdings Limited